Years of Experience: 20
Languages Spoken: English
Neurological movement disorders, including:
Dr. Farbman is currently conducting several clinical trials, and through the Roseman University College of Medicine, is a site for both the Parkinson Study Group and the Huntington Study Group with studies for patients experiencing mild, moderate, or severe symptoms. A new study will soon be started on multiple system atrophy, an atypical Parkinson-plus disorder with no current treatments, as well as an essential tremor study. Patients interested in enrolling in a clinical trial for Movement Disorders can call 702-463-4040, extension 1004 to learn more or email email@example.com.
This article was originally posted on Roseman University of Health Sciences’ blog, as well as published in the May/June edition of Roseman University’s print edition
Neuropathy, also known as peripheral neuropathy, affects an estimated 20 million people in the United States. According to the American Association of Neuromuscular & Electrodiagnostic